PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COM
Total 13F shares
8,829,720
Share change
-2,403,749
Total reported value
$3,853,840
Put/Call ratio
800%
Price per share
$0.44
Number of holders
27
Value change
-$702,596
Number of buys
8
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q1 2019

As of 31 Mar 2019, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,829,720 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Fosun International Ltd, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, SG Americas Securities, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, UBS Group AG, MEITAV DASH INVESTMENTS LTD, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Virtu Financial LLC, and VAN ECK ASSOCIATES CORP. This page lists 27 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.